Axios

@axios ↗

Deleted No

Hibernated Yes

Last Checked Oct. 26, 2022

Created

Fri Sep 02 18:40:30 +0000 2022

Likes

206

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Axios @axios

Paxlovid use surged over the summer, with as many as 1/3 of reported COVID cases treated with it. But uncertainty over what's causing the relapses, and whether the drug helps younger patients, is making some people wary of the treatment, physicians say. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Preceded By

Axios @axios

The FDA has asked Pfizer to investigate whether a second five-day course of the drug will prevent the virus from returning. Pfizer executives in May suggested patients who can't clear the virus with the first course should take more, Bloomberg reported. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Followed By

Axios @axios

At least part of the problem is that people are not routinely tested after taking Paxlovid, which makes it hard to establish how often rebound happens or why the virus lingers in some people, Leana Wen, a physician and a professor, told CNN. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated